India’s NDude Labs led $3 M Series A funding raised by US wellness brand SuperMush
NDude Labs, a healthcare and wellness investment firm operating in India and the US, has led a $3 million Series A funding round in US-based functional wellness brand SuperMush.
The company plans to use the fresh capital to broaden its product portfolio, develop new formulations, expand its team and strengthen customer support infrastructure.
Founded in 2022 by Alli Schaper and Brian Friedman, SuperMush creates wellness products incorporating ingredients such as nootropics, adaptogens and functional mushrooms. Its offerings include gummies containing Shilajit, Creatine and Lion’s Mane.
Expands retail presence across the US
Over the past year, SuperMush has expanded its distribution to more than 1,000 Target stores. The brand now sells through over 2,000 retail outlets across the US, including Target and Sprouts, in addition to its own website and Amazon.
With the new funding, SuperMush intends to grow across physical retail, direct-to-consumer sales and online marketplaces while continuing to invest in product innovation and formulation development.
NDude Labs expands wellness investment portfolio
The investment follows NDude Labs’ recent backing of Nutriventia, a company specialising in nutraceutical ingredients.
NDude Labs invests in healthcare and wellness businesses across India and the US, with its latest investment adding SuperMush to its portfolio of companies operating in the broader wellness sector.
